Kelly G. Huller - 25 Feb 2026 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Signature
/s/ Kelly G. Huller
Issuer symbol
GMED
Transactions as of
25 Feb 2026
Net transactions value
-$1,018,400
Form type
4
Filing time
27 Feb 2026, 17:53:36 UTC
Previous filing
17 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Huller Kelly EVP, GC, Corporate Secretary VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON /s/ Kelly G. Huller 27 Feb 2026 0001768417

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $871,600 +20,000 $43.58 20,000 25 Feb 2026 Direct
transaction GMED Class A Common Stock Sale $1,890,000 -20,000 -100% $94.50 0 25 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -20,000 -50% $0.000000 20,000 25 Feb 2026 Class A Common Stock 20,000 $43.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated November 12, 2025 executed by the reporting person.
F2 These options were granted on January 22, 2019 and are fully vested.